Stay updated on Atezolizumab in Esophageal Cancer: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.

Latest updates to the Atezolizumab in Esophageal Cancer: Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.3.SummaryDifference0.1%
- Check16 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.9%
- Check24 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check60 days agoChange DetectedThe web page has been updated to reflect new information regarding the clinical study for Esophageal Squamous Cell Carcinoma, including an increase in the number of study locations from 163 to 166 and the addition of specific locations in Chengdu, Chongqing, and Lyon. The study's timeline has also been updated with new dates in April 2025.SummaryDifference14%
- Check67 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 9, 2025.SummaryDifference0.3%
Stay in the know with updates to Atezolizumab in Esophageal Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.